|1.||Roberts, Ian: 31 articles (01/2015 - 01/2009)|
|2.||Shakur, Haleema: 14 articles (01/2014 - 01/2009)|
|3.||Perel, Pablo: 13 articles (06/2014 - 01/2010)|
|4.||Ker, Katharine: 9 articles (01/2015 - 12/2011)|
|5.||Roberts, I: 7 articles (06/2015 - 10/2011)|
|6.||Gruen, Russell L: 7 articles (04/2014 - 09/2010)|
|7.||Lukes, Andrea S: 6 articles (09/2012 - 04/2009)|
|8.||Lethaby, A: 6 articles (01/2008 - 01/2000)|
|9.||Zurakowski, David: 5 articles (05/2015 - 04/2005)|
|10.||Prieto-Merino, David: 5 articles (01/2014 - 03/2011)|
03/01/2004 - "Prophylactic administration of tranexamic acid decreases bleeding and transfusions after cardiac procedures but it is still unclear what the best dose and the most appropriate timing to get the best results are. "
09/07/1996 - "Tranexamic acid given during menstruation is a safe and highly effective treatment for excessive bleeding. "
07/01/2003 - "In a pilot, non-randomized trial we tested the efficacy of tranexamic acid (TXA), a potent fibrinolytic inhibitor, as adjunctive therapy in standard treatment of major upper gastrointestinal bleeding in dialysis patients. "
01/01/2012 - "Tranexamic acid has proven to be an effective treatment for heavy menstrual bleeding (HMB). "
10/01/2010 - "In this study, a new oral tranexamic acid treatment was well tolerated and significantly improved both menstrual blood loss and health-related quality of life in women with heavy menstrual bleeding. "
01/01/2011 - "In this study, low dose intra-articular tranexamic acid injection combined with 2-hour clamping drain was effective for reducing postoperative blood loss and transfusion requirement in CAS-TKR without significant difference in postoperative complications or functional outcomes."
04/01/2004 - "Regarding time-related changes of postoperative blood loss, significant reduction was observed during the first 2 h after surgery in the tranexamic acid group ( P<0.001). "
11/01/2015 - "Topical tranexamic acid was effective for reducing postoperative blood loss and transfusion requirements without increasing the prevalence of thromboembolic complications. "
07/01/1993 - "The authors thus conclude that antifibrinolytic therapy during CPB with tranexamic acid reduces postoperative blood loss, and shortens the operation time due to an improvement in hemostasis."
11/20/2013 - "However, this trial supports findings from previous studies showing that intravenous tranexamic acid can decrease postoperative blood loss."
|3.||Wounds and Injuries (Trauma)
01/01/2012 - "Results from a recent randomized, placebo-controlled trial suggest that the early treatment of trauma patients with tranexamic acid may result in a significant reduction of trauma-associated mortality."
10/01/2014 - "Tranexamic acid is effective in reducing blood loss during various types of surgery and after trauma. "
05/01/2013 - "Tranexamic acid is effective in trauma patients. "
03/01/2015 - "To explore whether, in our trauma network in a middle-income country, patients arrived at hospital soon enough after injury for tranexamic acid administration to be effective and safe. "
04/01/2015 - "Large clinical studies have demonstrated efficacy and safety of tranexamic acid (TXA) in the trauma population to reduce blood loss and transfusions. "
10/01/2012 - "Addition of oral tranexamic acid provides rapid and sustained improvement in the treatment of melasma."
07/01/2013 - "To compare the therapeutic efficacy and safety of tranexamic acid (TA) microinjections versus tranexamic acid with microneedling in melasma. "
08/01/2014 - "Topical tranexamic acid as a promising treatment for melasma."
07/01/2015 - "The efficacy of tranexamic acid in the treatment of melasma."
10/01/2012 - "To compare the efficacy of oral tranexamic acid with routine topical therapies for the treatment of melasma. "
05/01/1995 - "Tranexamic acid is a safe and effective form of medical therapy in women with menorrhagia and is highly likely to normalise blood loss in women losing 80 to 200 ml prior to treatment. "
01/01/2003 - "Nevertheless, tranexamic acid may be considered as a first-line treatment for the initial management of idiopathic menorrhagia, especially for patients in whom hormonal treatment is either not recommended or not wanted."
01/01/2003 - "In conclusion, the oral antifibrinolytic drug tranexamic acid is an effective and well tolerated treatment for idiopathic menorrhagia. "
10/01/2005 - "Tranexamic acid is a safe and effective form of medical therapy in women with menorrhagia; also increases quality of life in these women."
10/01/2005 - "To determine the efficacy of tranexamic acid in the treatment of idiopathic menorrhgia and to investigate the effect of medical treatment with tranexamic acid on the quality of life of the women with idiopathic menorrhagia. "
|2.||6-Aminocaproic Acid (6 Aminocaproic Acid)
|3.||Levonorgestrel (Plan B)
|4.||Antifibrinolytic Agents (Antifibrinolytics)
|5.||Deamino Arginine Vasopressin (Desmopressin)
|6.||Aminocaproic Acids (EAC)
|7.||Tranexamic Acid (AMCA)
|8.||Medroxyprogesterone Acetate (Depo-Provera)
|9.||recombinant FVIIa (rFVIIa)
|1.||Blood Transfusion (Blood Transfusions)
|3.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|5.||Platelet Transfusion (Blood Platelet Transfusions)